speb/financial-data huggingface dataset:
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -233800000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 115828357000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 115828357000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -879358000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 2339932000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 101187629000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 101187629000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 5936508000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 5936508000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 1393447000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 1393447000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 3956575000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1789500000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 404362800.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 689653191.80
INDIACEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -267347000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Operating Income: 972147000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 772400000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 44544212000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 12286500000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 309898366.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 309898366.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 2000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2885000000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2885000000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 854783000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 854783000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 98143700000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 98143700000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 55078000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 55078000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 133809000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 133809000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 796282000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 904400000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 904400000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 202167000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 258500000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1582898000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 6399800000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 655132000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 655132000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 111816200000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 111816200000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 584206000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 584206000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 484737000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 484737000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Other Special Charges: -225421000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Payables: 9315800000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 9315800000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 77181000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 3528621000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3528621000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Pretax Income: -650082000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 687700000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 187226000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -421979000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -2226719000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 5879713000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 5879713000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 29567146000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3380000000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2991249000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 758600000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 114735000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 114735000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 3097000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 3097000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 32532000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1347361000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 6259399000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 346800000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 7186698000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 346800000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 309898366.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 309898366.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: -1072392000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -109400000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 101242707000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 101242707000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 101187629000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 101187629000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -424755200.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -14746808.20
INDIACEM.NS income_statement (annual, 2026-03-31) — Tax Provision: 22422000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 92700000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 643600000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 643600000.00
INDIACEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -82347000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 134030460000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 134030460000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 110981008000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 110981008000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 13048031000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 13048031000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 101242707000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 101242707000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 43572065000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 11514100000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 32787753000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 32787753000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 118185996000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 118185996000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 17030829000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 17030829000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 400000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 400000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -622154000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -109400000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1061888000.00
INDIACEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -109400000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 1115330000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 1115330000.00
INDIACEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 87540000.00
INDIACEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 87540000.00
INDIACEM.NS income_statement (annual, 2026-03-31) — Write Off: 383847000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 7019800000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 10194200000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 308620690.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 0.87
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 2336600000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 719400000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 719400000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 308620690.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.87
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — EBIT: 619500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — EBITDA: 1338900000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 7857600000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 261500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 261500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Minority Interests: 0.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income Discontinuous Operations: 0.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income Extraordinary: 0.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 268500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -261500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -261500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 1591700000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 458100000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Operating Income: 837800000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 10194200000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 34500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 5622600000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Other Special Charges: 252800000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 358000000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 2336600000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 719400000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 201500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Selling General And Administration: 201500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: -252800000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: -63200000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 89500000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 9356400000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: -252800000.00
INDIACEM.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: -252800000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4073487000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 395855000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -7879000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Amortization: 2187000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2187000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Basic EPS: 54.89
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1308741000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 70474000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Current Deferred Assets: 1275600000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 261819000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 54.89
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 12009000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1747689000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -1458000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -2213386000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 489931000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 3994690000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Interest Income: 242505000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 242505000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2747048000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 22886194000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Minority Interest: -194772000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 4584882000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 102665000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 1458000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -79353000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -166776000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Assets: 10846000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 1888392000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 45792000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 403302000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 9894000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 2450001000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 2400230000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -2212491000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 37496000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 49000000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 383612000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 4282790000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 25251000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 25251000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 946714000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: -2213400000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 16062271000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 4584882000.00
INDIAGLYCO.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 1458000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 933984000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1423915000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 154051000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 129809000.00
INDIAGLYCO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 889552000.00
INDIAGLYCO.NS income_statement (annual, 2022-03-31) — Write Off: 1326732000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 7115656000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 25770184000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 8029694000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 4303366000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4389452000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 395855000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -7879000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Amortization: 2359000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2359000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 443000000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Basic EPS: 22.78
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 70474000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1307834000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4387740000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 182024000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 309615000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 19738000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 476723000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -230365000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 19738000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -636249000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Change In Payable: 698411000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 868636000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 930798000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -50736000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 309615000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -230365000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 19014190000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1304204000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 16314913000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 16462383000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 38291000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 5432971000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 5471262000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Deferred Assets: 1010269000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 18649251000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 27500000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Depreciation: 937255000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 939614000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 939614000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 937255000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 22.78
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1250844000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 13855000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — EBIT: 2500167000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — EBITDA: 3439781000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 19738000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -5069000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 1459715000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1130626000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -282695000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -14338000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 475466000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 18973000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 4311245000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 32767355000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Gross Profit: 9455271000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Interest Expense: 850105000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 850105000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Interest Income: 247171000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 247171000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -989728000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 239260000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Inventory: 7538326000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 29954843000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3302781000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 76126000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 443000000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 3184727000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2971270000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2255198000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 143733000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 5507682000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5651415000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2971270000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1659980000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 3184727000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 44500000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 27686775000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Minority Interests: -159590000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Net Debt: 10920915000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -36268000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income: 1250844000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1250844000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1410434000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 0.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1250844000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1250844000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1536344000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1410434000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Interest Income: -785749000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 553128000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1311290000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1311290000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -785749000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 28377903000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -4346619000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 18995217000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 6506000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1164121000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 3589318000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 44490000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 397062000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 3142748000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Normalized Income: 996947211.68
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 3257114000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Operating Income: 2339615000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 25770184000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1730300000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 2439500000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 18704600000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 18973000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 14105000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 784557000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 73900000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1164100000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 8013000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 4770222000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2725489000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 213344000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1724319000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 456985000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -295698000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Payables: 10940140000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27496000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 637220000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Pretax Income: 1650062000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -98271000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -4387740000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 5188003000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 16314913000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 939614000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 26321000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 26321000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1659980000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 1112918000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 17153726000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 553128000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 41121000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 653706000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1129172000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Special Income Charges: 295698000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 19014190000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 18995217000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 43136211.68
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Tax Provision: 239628000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.15
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 669511000.00
INDIAGLYCO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -502627000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 48583331000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 24521872000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 11122677000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 19014190000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Total Expenses: 23430569000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 29569141000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 32120948000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 10919890000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 182815000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 171102000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 297033000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 297033000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 876503000.00
INDIAGLYCO.NS balance_sheet (annual, 2023-03-31) — Working Capital: -2186868000.00
INDIAGLYCO.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 7360687000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 32686403000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 11699861000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3841017000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5384804000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 395855000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -52879000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Amortization: 2710000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2710000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 425200000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Basic EPS: 27.94
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 19738000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1404792000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -5529261000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 271234000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 309615000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 269569000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 746420000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -229719000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 269569000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -3524526000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 3246806000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 620448000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 342728000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 249831000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 309615000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -229719000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 20510167000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 874830000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 22134423000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 19447005000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 69636000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 5960255000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 6029891000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 23747342000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 27400000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Depreciation: 1004968000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1007678000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1007678000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1004968000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 27.94
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1729931000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 16347000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — EBIT: 3284385000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — EBITDA: 4292063000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 269569000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 899123000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 1307046000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -1144008000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -1761000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -38850000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 501348000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 16263000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3893896000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 38227262000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Gross Profit: 10551980000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Interest Expense: 1051238000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1051238000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Interest Income: 235805000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 235805000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1228627000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 383783000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Inventory: 11062852000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 33721186000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -5034545000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 65567000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 425200000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 3351427000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 4633048000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2206231000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 201598000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 7250764000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 7452362000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 4633048000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2364719000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 3351427000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 48500000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 33375295000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Net Debt: 12941450000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 69860000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income: 1729931000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1729931000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1729931000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1729931000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1729931000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2066516000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1729931000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -999028000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 1761000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 2268329000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 2268329000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -999028000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 32842458000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -5420089000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 20493904000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 29579000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 3984142000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 48535000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 439832000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 4258687000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Normalized Income: 1704075927.74
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 4385253000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Operating Income: 3191293000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 32686403000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 61923000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1830100000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2945100000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 189000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 16263000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 5845000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 997836000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 53900000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 29600000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 5298000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 4164509000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 3121785000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 366114000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 1127593000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 476851000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -38850000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Payables: 15009069000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 27417000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 415543000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Pretax Income: 2233147000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -1882000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -5529261000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 8770827000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 22134423000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1007678000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 103948000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 103948000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -2364719000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1108704000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 18651635000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 1761000.00
INDIAGLYCO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 109172000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 800017000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1301365000.00
INDIAGLYCO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 61923000.00
INDIAGLYCO.NS income_statement (annual, 2024-03-31) — Special Income Charges: 31615000.00